Mirum Pharmaceuticals, Inc. (MIRM) Operating margin 2021–2025
Mirum Pharmaceuticals, Inc. (MIRM) operating margin by fiscal year — reported operating income divided by reported revenue.
-4.2%FY2025 · since FY2021: -906.1% → -4.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.2% | +21.8 pp |
| FY2024 | -26.0% | +32.6 pp |
| FY2023 | -58.6% | +111.7 pp |
| FY2022 | -170.3% | +735.8 pp |
| FY2021 | -906.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating cash flowMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →